Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chromaturia, Fatigue, Hypertension, Nausea, Protein urine
Clinical narrative: Rust colored urine; Fever; chills; Aching joints; Nausea; vomiting; fatigue; Elevated c-reactive protein; Elevated urine RBC/HPF; Elevated urine albumin/creatinine ratio; Elevated urine total protein; High blood pressure on exam; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 31-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 08Dec2021 (Lot number: 33030BD) at the age of 31 Years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history was reported as none. Concomitant medications were not reported. Past drug history included: Cephalexin, reactions: "Drug allergy". Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Lot number: E13249.), administration date: 28Jan2021, when the patient was 30 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 1, SINGLE, Lot number: E13246.), administration date: 07Jan2021, when the patient was 30 years old, for COVID-19 immunisation.  The following information was reported: CHROMATURIA (non-serious) with onset 09Dec2021, outcome "not recovered", described as "Rust colored urine"; PYREXIA (non-serious) with onset 09Dec2021, outcome "not recovered", described as "fever"; CHILLS (non-serious) with onset 09Dec2021, outcome "not recovered", described as "chills"; ARTHRALGIA (non-serious) with onset 09Dec2021, outcome "not recovered", described as "aching joints"; NAUSEA (non-serious) with onset 09Dec2021, outcome "not recovered", described as "nausea"; VOMITING (non-serious) with onset 09Dec2021, outcome "not recovered", described as "vomiting"; FATIGUE (non-serious) with onset 09Dec2021, outcome "not recovered", described as "fatigue"; C-REACTIVE PROTEIN INCREASED (non-serious) with onset 09Dec2021, outcome "not recovered", described as "elevated c-reactive protein"; RED BLOOD CELLS URINE POSITIVE (non-serious) with onset 09Dec2021, outcome "not recovered", described as "Elevated urine RBC/HPF"; URINE ALBUMIN/CREATININE RATIO INCREASED (non-serious) with onset 09Dec2021, outcome "not recovered", described as "Elevated urine albumin/creatinine ratio"; PROTEIN URINE PRESENT (non-serious) with onset 09Dec2021, outcome "not recovered", described as "Elevated urine total protein"; HYPERTENSION (non-serious) with onset 09Dec2021, outcome "not recovered", described as "High blood pressure on exam". The events "Rust colored urine", "fever", "chills", "aching joints", "nausea", "vomiting", "fatigue", "elevated c-reactive protein", "Elevated urine RBC/HPF", "Elevated urine albumin/creatinine ratio", "Elevated urine total protein" and "High blood pressure on exam" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chromaturia, pyrexia, chills, arthralgia, nausea, vomiting, fatigue, c-reactive protein increased, red blood cells urine positive, urine albumin/creatinine ratio increased, protein urine present and hypertension.  Additional Information: Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested for COVID-19.